The serpin protease-nexin 1 is present in rat aortic smooth muscle cells and is upregulated in L-NAME hypertensive rats

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 1, 2003, Pages 142-147

  Bouton, Marie Christine ^a   Richard, Benjamin ^a   Rossignol, Patrick ^a   Philippe, Monique ^a   Guillin, Marie Claude ^a   Michel, Jean Baptiste ^a   Jandrot Perrus, Martine ^a  

^a INSERM   (France)

Author keywords

Aorta; Hypertension; Protease nexin 1; Smooth muscle cells; Thrombin

Indexed keywords

CALCIUM ION; IODINE 125; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; PROTEASE NEXIN I; THROMBIN; THROMBIN INHIBITOR; ZOFENOPRIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; AORTA WALL; ARTICLE; CALCIUM MOBILIZATION; COMPLEX FORMATION; CONTROLLED STUDY; COVALENT BOND; HEART RATE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ADMINISTRATION, ORAL; AMYLOID BETA-PROTEIN PRECURSOR; ANGIOTENSIN II; ANIMALS; AORTA; CALCIUM; CARRIER PROTEINS; CELL DIVISION; CELLS, CULTURED; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE DONORS; RATS; RATS, WISTAR; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SERPINS; THROMBIN; UP-REGULATION;

EID: 0037231658     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000047867.98019.2D     Document Type: Article

References (32)

1. Reinhard E, Meier R, Halfter W, Rovelli G, Monard D. Detection of glia-derived nexin in the olfactory system of the rat. Neuron. 1988;1:387-394.
2. Baker JB, Low DA, Simmer RL, Cunningham DD. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell. 1980;21:37-45.
3. Mbebi C, Hantai D, Jandrot-Perrus M, Doyennette MA, Verdiere-Sahuque M. Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors. J Cell Physiol. 1999;179:305-314.
4. Cunningham DD, Pulliam L, Vaughan PJ. Protease nexin-1 and thrombin: injury-related processes in the brain. Thromb Haemost. 1993;70:168-171.
5. Knauer MF, Kridel SJ, Hawley SB, Knauer DJ. The efficient catabolism of thrombin-protease nexin 1 complexes is a synergistic mechanism that requires both the LDL receptor-related protein and cell surface heparins. J Biol Chem. 1997;272:29039-29045.
6. Wagner SL, Lau AL, Cunningham DD. Binding of protease nexin-1 to the fibroblast surface alters its target proteinase specificity. J Biol Chem. 1989;264:611-615.
7. Donovan FM, Vaughan PJ, Cunningham DD. Regulation of protease nexin-1 target protease specificity by collagen type IV. J Biol Chem. 1994;269:17199-17205.
8. Stone SR, Nick H, Hofsteenge J, Monard D. Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin, thrombin, and urokinase. Arch Biochem Biophys. 1987;252:237-244.
9. Patterson C, Stouffer GA, Madamanchi N, Runge MS. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology. Circ Res. 2001;88:987-997.
10. Smith EB, Crosbie L, Carey S. Prothrombin-related antigens in human aortic intima. Semin Thromb Hemost. 1996;22:347-350.
11. Stoop AA, Lupu F, Pannekoek H. Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: a potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes. Arterioscler Thromb Vasc Biol. 2000;20:1143-1149.
12. Bezeaud A, Denninger MH, Guillin MC. Interaction of human alphathrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin. Eur J Biochem. 1985;153:491-496.
13. Sommer J, Gloor SM, Rovelli GF, Hofsteenge J, Nick H, Meier R, Monard D. cDNA sequence coding for a rat glia-derived nexin and its homology to members of the serpin superfamily. Biochemistry. 1987;26:6407-6410.
14. Battle T, Arnal JF, Challah M, Michel JB. Selective isolation of rat aortic wall layers and their cell types in culture: application to converting enzyme activity measurement. Tissue Cell. 1994;26:943-955.
15. Lepailleur-Enouf D, Valdenaire O, Philippe M, Jandrot-Perrus M, Michel JB. Thrombin induces endothelin expression in arterial smooth muscle cells. Am J Physiol Heart Circ Physiol. 2000;278:H1606-H1612.
16. Bleuel A, de Gasparo M, Whitebread S, Puttner I, Monard D. Regulation of protease nexin-1 expression in cultured Schwann cells is mediated by angiotensin II receptors. J Neurosci. 1995;15:750-761.
17. Markwardt F. Hirudin and derivatives as anticoagulant agents. Thromb Haemost. 1991;66:141-152.
18. Zatz R, Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension. 1998;32:958-964.
19. Corseaux D, Ollivier V, Fontaine V, Huisse MG, Philippe M, Louedec L, Vranckx R, Ravanat C, Lanza F, Angles-Cano E, Guillin MC, Michel JB. Hemostasis imbalance in experimental hypertension. Mol Med. 2002;8:169-178.
20. Luvara G, Pueyo ME, Philippe M, Mandet C, Savoie F, Henrion D, Michel JB. Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism. Arterioscler Thromb Vasc Biol. 1998;18:1408-1416.
21. Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, Vaughan DE. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation. 2001;104:839-844.
22. Henrion D, Dowell FJ, Levy BI, Michel JB. In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. Hypertension. 1996;28:361-366.
23. Eaton DL, Baker JB. Evidence that a variety of cultured cells secrete protease nexin and produce a distinct cytoplasmic serine protease-binding factor. J Cell Physiol. 1983;117:175-182.
24. Akaaboune M, Hantai D, Smirnova I, Lachkar S, Kapsimali M, Verdiere-Sahuque M, Festoff BW. Developmental regulation of the serpin, protease nexin 1, localization during activity-dependent polyneuronal synapse elimination in mouse skeletal muscle. J Comp Neurol. 1998;397:572-579.
25. Knauer DJ, Majumdar D, Fong PC, Knauer MF. SERPIN regulation of factor Xia: the novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor. J Biol Chem. 2000;275:37340-37346.
26. Murer V, Spetz JF, Hengst U, Altrogge LM, de Agostini A, Monard D. Male fertility defects in mice lacking the serine protease inhibitor protease nexin-1. Proc Natl Acad Sci U S A. 2001;98:3029-3033.
27. Gonzalez W, Fontaine V, Pueyo ME, Laquay N, Messika-Zeitoun D, Philippe M, Arnal JF, Jacob MP, Michel JB. Molecular plasticity of vascular wall during N(G)-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension. 2000;36:103-109.
28. van Leeuwen RT, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation. 1994;90:362-368.
29. Bouchie JL, Hansen H, Feener EP. Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells: role of cGMP in the regulation of the plasminogen system. Arterioscler Thromb Vasc Biol. 1998;18:1771-1779.
30. Vaughan PJ, Cunningham DD. Regulation of protease nexin-1 synthesis and secretion in cultured brain cells by injury-related factors. J Biol Chem. 1993;268:3720-3727.
31. Guttridge DC, Lau AL, Cunningham DD. Protease nexin-1, a thrombin inhibitor, is regulated by interleukin-1 and dexamethasone in normal human fibroblasts. J Biol Chem. 1993;268:18966-18974.
32. Capers Qt, Laursen JB, Fukui T, Rajagopalan S, Mori I, Lou P, Freeman BA, Berrington WR, Griendling KK, Harrison DG, Runge MS, Alexander RW, Taylor WR. Vascular thrombin receptor regulation in hypertensive rats. Circ Res. 1997;80:838-844.